The effect of quetiapine on auditory P300 response in patients with schizoaffective disorder: Preliminary study

Annals of Clinical Psychiatry

Volumn 21, Issue 1, 2009, Pages 49-50

  Korostenskaja, Milena ^a   Dapsys, Kastytis ^b   Siurkute, Aldona ^c   Dudlauskaite, Akvile ^b   Pragaraviciene, Audra ^d   Maciulis, Valentinas ^b   Kähkönen, Seppo ^e  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Republican Vilnius Psychiatric Hospital   (Lithuania)

^c VILNIUS UNIVERSITY   (Lithuania)

^d VYTAUTAS MAGNUS UNIVERSITY   (Lithuania)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antipsychotics; ERPs; P300; Quetiapine; Schizophrenia

Indexed keywords

DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; QUETIAPINE;

ADULT; DRUG EFFECT; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; LETTER; MALE; PSYCHOLOGICAL ASPECT; PSYCHOSIS;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS;

EID: 67650112821     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Iwanami A, Okajima Y, Isono H, et al. Effects of risperidone on event-related potentials in schizophrenic patients. Pharmacopsychiatry. 2001;34:73-79.
2. Niznikiewicz MA, Patel JK, McCarley R, et al. Clozapine action on auditory P3 response in schizophrenia. Schizophr Res. 2005;76:119-121.
3. Gallinat J, Riedel M, Juckel G, et al. P300 and symptom improvement in schizophrenia. Psychopharmacology (Berl). 2001;158:55-65.
4. Araki T, Kasai K, Rogers MA, et al. The effect of perospirone on auditory P300 in schizophrenia: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1083-1090.
5. World Health Organization. International Statistical Classification of Diseases and Health Related Problems, 10th revision, 2nd ed. Geneva: World Health Organization; 2004.
6. Korostenskaja M, Dapsys K, Siurkute A, et al. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:543-548.